H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)

September 17, 2026 6:54 AM

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating and $7.00 price target on Connect Biopharma Holdings Ltd (NASDAQ: CNTB).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found